HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nozomi Niitsu Selected Research

6-sulfo sialyl Lewis X

8/2002Expression of cutaneous lymphocyte antigen is associated with a poor outcome of nasal-type natural killer-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nozomi Niitsu Research Topics

Disease

10B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 08/2002
10Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2015 - 09/2006
10Lymphoma (Lymphomas)
03/2014 - 02/2002
8Neoplasms (Cancer)
02/2015 - 08/2002
5Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2010 - 02/2002
4Leukemia
01/2018 - 11/2002
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2005 - 11/2002
2Hodgkin Disease (Hodgkin's Disease)
11/2011 - 09/2006
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2011 - 01/2007
2Acute Promyelocytic Leukemia
07/2010 - 11/2002
2Cardiotoxicity
01/2005 - 11/2002
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
11/2003 - 02/2002
1Neoplasm Metastasis (Metastasis)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Pericardial Effusion
12/2014
1T-Cell Lymphoma (Lymphoma, T Cell)
05/2011
1Infections
12/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2010
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2010
1Rheumatoid Arthritis
05/2010
1Marfan Syndrome (Marfan's Syndrome)
03/2010
1Plasmablastic Lymphoma
01/2010
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2009
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2008
1Cardiomyopathies (Cardiomyopathy)
01/2005
1Pancytopenia
11/2004
1Paralysis (Palsy)
11/2003
1Myeloid Leukemia (Leukemia, Myelocytic)
11/2002
1Carcinogenesis
11/2002

Drug/Important Bio-Agent (IBA)

13Rituximab (Mabthera)FDA Link
01/2020 - 06/2004
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 06/2004
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 06/2004
5Vincristine (Oncovin)FDA LinkGeneric
01/2020 - 06/2004
4Prednisolone (Predate)FDA LinkGeneric
01/2020 - 11/2003
4Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018 - 08/2002
4Proteins (Proteins, Gene)FDA Link
01/2014 - 04/2003
3Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 11/2003
3Monoclonal AntibodiesIBA
03/2014 - 06/2004
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2007 - 11/2003
3Etoposide (VP 16)FDA LinkGeneric
09/2006 - 01/2005
3Prednisone (Sone)FDA LinkGeneric
06/2006 - 06/2004
2Bendamustine HydrochlorideFDA Link
02/2015 - 06/2013
2Granzymes (Granzyme)IBA
02/2010 - 11/2003
2Irinotecan (Camptosar)FDA LinkGeneric
01/2007 - 09/2006
2Mitoxantrone (Novantrone)FDA LinkGeneric
01/2007 - 09/2006
2Bleomycin (Blenoxane)FDA LinkGeneric
09/2006 - 06/2006
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2005 - 06/2004
1lysophosphatidic acidIBA
01/2018
1Lysophosphatidic Acid ReceptorsIBA
01/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2015
1Proteasome InhibitorsIBA
03/2014
1Histones (Histone)IBA
03/2014
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2013
1fascinIBA
11/2011
1Biomarkers (Surrogate Marker)IBA
06/2011
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2011
1Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2010
1Ellagic AcidIBA
07/2010
1Pharmaceutical PreparationsIBA
07/2010
1AntioxidantsIBA
07/2010
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
03/2010
1Transforming Growth Factor beta (TGF-beta)IBA
03/2010
1FibrillinsIBA
03/2010
1Dacarbazine (DIC)FDA LinkGeneric
06/2009
1Pyridinolcarbamate (P23)IBA
06/2009
1growth arrest specific transcript 5IBA
04/2008
1Procarbazine (Matulane)FDA Link
09/2006
1Melphalan (Alkeran)FDA LinkGeneric
11/2005
1Immunoglobulin G (IgG)IBA
11/2005
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2005
1Troponin T (Troponin T1)IBA
01/2005
1ProgesteroneFDA LinkGeneric
11/2004
1theasinensin AIBA
05/2004
1Interleukin-2 Receptors (IL 2 Receptor)IBA
04/2004
1C-Reactive ProteinIBA
04/2004
1Biological ProductsIBA
04/2003
11,2-bis(3,5-dioxopiperazin-1-yl)ethaneIBA
11/2002
1Catalytic DNA (Deoxyribozyme)IBA
11/2002
1Topoisomerase II InhibitorsIBA
11/2002
14,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedioneIBA
11/2002
16-sulfo sialyl Lewis XIBA
08/2002
1Interferon-gamma (Interferon, gamma)IBA
08/2002
1ImmunosorbentsIBA
03/2002
1EnzymesIBA
03/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2002
1Interleukin-6 (Interleukin 6)IBA
02/2002

Therapy/Procedure

9Drug Therapy (Chemotherapy)
01/2020 - 11/2002
7Therapeutics
06/2013 - 08/2002
5Radiotherapy
12/2014 - 11/2002
2PACEBO protocol
06/2011 - 12/2006
2VAP-cyclo protocol
06/2010 - 06/2004
1Stem Cell Transplantation
06/2013
1Combination Drug Therapy (Combination Chemotherapy)
12/2010
1Splenectomy
01/2009
1Salvage Therapy
01/2005
1Cesarean Section (Caesarean Section)
11/2004
1Hysterectomy
11/2002
1Salpingo-oophorectomy
11/2002